Nadir Böbrek Tümörleri

Ljungberg B, Campbell SC, Choi HY, et al. The epidemiology of renal cell carcinoma. European urology. 2011;60(4):615-21.doi.10.1016/j.eururo.2011.06.049 E2. Gray RE, Harris GT. Renal Cell Carcinoma: Diagnosis and Management. American family physician. 2019;99(3):179-84

http://gco.iarc.fr/tomorrow/graphic-isotype.

Lopez-Beltran A, Carrasco JC, Cheng L, et al. 2009 update on the classification of renal epithelial tumors in adults. International journal of urology : official journal of the Japanese Urological Association. 2009;16(5):432-43.doi.10.1111/j.1442-2042.2009.02302.x

Warren AY, Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World journal of urology. 2018;36(12):1913-26.doi.10.1007/s00345-018-2447-8

Katabathina VS, Vikram R, Nagar AM, et al. Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2010;30(6):1525-40.doi.10.1148/rg.306105517

Moch H, Ohashi R. Chromophobe renal cell carcinoma: current and controversial issues. Pathology. 2021;53(1):101-8.doi.10.1016/j.pathol.2020.09.015

Maiti A, Brown RE, Corn PG, et al. Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates. Clinical genitourinary cancer. 2016;14(2):e187-93.doi.10.1016/j.clgc.2015.11.004

Manipadam MT, Korula A, Chandrasingh J, et al. Chromophobe renal cell carcinoma: A report of two cases with unusual histological features. Indian journal of urology : IJU : journal of the Urological Society of India. 2008;24(1):123-5.doi.10.4103/0970-1591.38620

Othmane Y, Mounir L, Tarik K, et al. [Chromophobe renal cell carcinoma: about four cases and review of the literature]. The Pan African medical journal. 2015;22:123.doi.10.11604/pamj.2015.22.123.6741

Marko J, Craig R, Nguyen A, et al. Chromophobe Renal Cell Carcinoma with Radiologic-Pathologic Correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2021;41(5):1408-19.doi.10.1148/rg.2021200206

Erlmeier F. [Chromophobe renal cell carcinoma-diagnosis and prognosis]. Der Pathologe. 2019;40(Suppl 3):252-8.doi.10.1007/s00292-019-00696-5

Muglia VF, Prando A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiologia brasileira. 2015;48(3):166-74.doi.10.1590/0100-3984.2013.1927

Yusenko MV. Molecular pathology of chromophobe renal cell carcinoma: a review. International journal of urology : official journal of the Japanese Urological Association. 2010;17(7):592-600.doi.10.1111/j.1442-2042.2010.02558.x

Keizman D, Sarid D, Lee JL, et al. Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib. The oncologist. 2016;21(10):1212-7.doi.10.1634/theoncologist.2015-0428

Armstrong AJ, Halabi S, Eisen T, et al. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. The Lancet Oncology. 2016;17(3):378-88.doi.10.1016/S1470-2045(15)00515-X

Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Seminars in diagnostic pathology. 1998;15(1):54-67

Peyromaure M, Thiounn N, Scotte F, et al. Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases. The Journal of urology. 2003;170(4 Pt 1):1138-40.doi.10.1097/01.ju.0000086616.40603.ad

Roupret M, Peyromaure M, Hupertan V, et al. [Bellini renal cell carcinoma. Diagnosis and treatment]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2004;14(4):564-7

Oueslati A, Saadi A, Chakroun M, et al. Bellini duct carcinoma revealed by cutaneous metastasis: A case report. International journal of surgery case reports. 2020;76:195-8.doi.10.1016/j.ijscr.2020.09.156

Outwater EK, Bhatia M, Siegelman ES, et al. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology. 1997;205(1):103-7.doi.10.1148/radiology.205.1.9314970

Orsola A, Trias I, Raventos CX, et al. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma. Urology. 2005;65(1):49-54.doi.10.1016/j.urology.2004.08.012

Tokuda N, Naito S, Matsuzaki O, et al. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. The Journal of urology. 2006;176(1):40-3; discussion 3.doi.10.1016/S0022-5347(06)00502-7

Catalano C, Fraioli F, Laghi A, et al. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR American journal of roentgenology. 2003;180(5):1271-7.doi.10.2214/ajr.180.5.1801271

Mishra AK, Manikandan R, Dorairajan LN, et al. Bellini Duct Carcinoma: A Rare Entity. Journal of clinical and diagnostic research : JCDR. 2016;10(10):PD01-PD2.doi.10.7860/JCDR/2016/21335.8613

Motzer RJ, Bacik J, Mariani T, et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002;20(9):2376-81.doi.10.1200/JCO.2002.11.123

Dason S, Allard C, Sheridan-Jonah A, et al. Management of renal collecting duct carcinoma: a systematic review and the McMaster experience. Current oncology. 2013;20(3):e223-32.doi.10.3747/co.20.1230

Murad T, Komaiko W, Oyasu R, et al. Multilocular cystic renal cell carcinoma. American journal of clinical pathology. 1991;95(5):633-7.doi.10.1093/ajcp/95.5.633

Gonzalez-Serrano A, Cortez-Betancourt R, Alias-Melgar A, et al. Multilocular Cystic Renal Cell Carcinoma or Cystic Nephroma? Case reports in urology. 2016;2016:5304324.doi.10.1155/2016/5304324

Gong K, Zhang N, He Z, et al. Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases. Journal of cancer research and clinical oncology. 2008;134(4):433-7.doi.10.1007/s00432-007-0302-1

Pitra T, Pivovarcikova K, Alaghehbandan R, et al. A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist's Perspective. Cancers. 2022;14(3).doi.10.3390/cancers14030831

Prasad SR, Humphrey PA, Catena JR, et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2006;26(6):1795-806; discussion 806-10.doi.10.1148/rg.266065010

Hindman NM, Bosniak MA, Rosenkrantz AB, et al. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings. AJR American journal of roentgenology. 2012;198(1):W20-6.doi.10.2214/AJR.11.6762

Eble JN, Bonsib SM. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Seminars in diagnostic pathology. 1998;15(1):2-20

Wahal SP, Mardi K. Multilocular cystic renal cell carcinoma: a rare entity with review of literature. Journal of laboratory physicians. 2014;6(1):50-2.doi.10.4103/0974-2727.129093

Carter SA, Walker AN. Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases. Journal of the National Medical Association. 2017;109(1):63-5.doi.10.1016/j.jnma.2016.08.006

Holland P, Merrimen J, Pringle C, et al. Renal medullary carcinoma and its association with sickle cell trait: a case report and literature review. Current oncology. 2020;27(1):e53-e6.doi.10.3747/co.27.5043

Shetty A, Matrana MR. Renal medullary carcinoma: a case report and brief review of the literature. The Ochsner journal. 2014;14(2):270-5

Levi Sandri GB, Spoletini G, Lai Q, et al. Cystic presentation of a renal medullary carcinoma in a young woman. Urologia. 2015;82(2):124-6.doi.10.5301/uro.5000097

Walsh A, Kelly DR, Vaid YN, et al. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma. Pediatric blood & cancer. 2010;55(6):1217-20.doi.10.1002/pbc.22611

Song HJ, Ma J, Zhou HB, et al. [Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathological study]. Zhonghua bing li xue za zhi = Chinese journal of pathology. 2011;40(7):444-8

Ged Y, Chen YB, Knezevic A, et al. Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes. Clinical genitourinary cancer. 2019;17(4):268-74 e1.doi.10.1016/j.clgc.2019.04.006

Nathany S, Monappa V. Mucinous Tubular and Spindle Cell Carcinoma: A Review of Histopathology and Clinical and Prognostic Implications. Archives of pathology & laboratory medicine. 2020;144(1):115-8.doi.10.5858/arpa.2017-0506-RS

Egbert ND, Caoili EM, Cohan RH, et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR American journal of roentgenology. 2013;201(2):347-55.doi.10.2214/AJR.12.9451

Zou ZG, Wang YH, Zhou JX, et al. [Renal mucinous tubular and spindle cell carcinoma: clinicopathological and whole exome sequencing analyses]. Zhonghua bing li xue za zhi = Chinese journal of pathology. 2021;50(7):762-7.doi.10.3760/cma.j.cn112151-20200922-00731

Hussain M, Ud Din N, Azam M, et al. Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathologic study of six cases. Indian journal of pathology & microbiology. 2012;55(4):439-42.doi.10.4103/0377-4929.107776

Koshkin VS, Barata PC, Zhang T, et al. Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma. Journal for immunotherapy of cancer. 2018;6(1):9.doi.10.1186/s40425-018-0319-9

Sun G, Chen J, Liang J, et al. Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma. Nature communications. 2021;12(1):5262.doi.10.1038/s41467-021-25618-z

Ellis CL, Eble JN, Subhawong AP, et al. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2014;27(6):875-86.doi.10.1038/modpathol.2013.208

Kmetec A, Jeruc J. Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype. Radiology and oncology. 2014; 48(2): 197-202.doi.10.2478/raon-2013-0077

Armah HB, Parwani AV. Xp11.2 translocation renal cell carcinoma. Archives of pathology & laboratory medicine. 2010;134(1):124-9.doi.10.1043/2008-0391-RSR.1 10.5858/2008-0391-RSR.1

Koo HJ, Choi HJ, Kim MH, et al. Radiologic-pathologic correlation of renal cell carcinoma associated with Xp11.2 translocation. Acta radiologica. 2013;54(7):827-34.doi.10.1177/0284185113484019

Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2009;22 Suppl 2:S2-S23.doi.10.1038/modpathol.2009.70

Pansadoro A, Cochetti G, D'Amico F, et al. Retroperitoneal laparoscopic renal tumour enucleation with local hypotension on demand. World journal of urology. 2015;33(3):427-32.doi.10.1007/s00345-014-1325-2

Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. European urology. 2015;67(5):913-24.doi.10.1016/j.eururo.2015.01.005

Kakoki K, Miyata Y, Mochizuki Y, et al. Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature. Clinical genitourinary cancer. 2017;15(3):e503-e6.doi.10.1016/j.clgc.2016.12.026

Rua Fernandez OR, Escala Cornejo R, Navarro Martin M, et al. Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene-fusion: A Long Response to mammalian target of rapamycin (mTOR) Inhibitors. Urology. 2018;117:41-3.doi.10.1016/j.urology.2018.03.032

Donnelly LF, Rencken IO, Shardell K, et al. Renal cell carcinoma after therapy for neuroblastoma. AJR American journal of roentgenology. 1996;167(4):915-7.doi.10.2214/ajr.167.4.8819382

Fleitz JM, Wootton-Gorges SL, Wyatt-Ashmead J, et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatric radiology. 2003;33(8):540-5.doi.10.1007/s00247-003-0913-x

Perlman EJ. Pediatric Renal Cell Carcinoma. Surgical pathology clinics. 2010;3(3):641-51.doi.10.1016/j.path.2010.06.011

Medeiros LJ, Palmedo G, Krigman HR, et al. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. The American journal of surgical pathology. 1999;23(7):772-80.doi.10.1097/00000478-199907000-00004

Falzarano SM, McKenney JK, Montironi R, et al. Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms. The American journal of surgical pathology. 2016;40(7):989-97.doi.10.1097/PAS.0000000000000632

Ogunbiyi MO, Rodriguez-Justo M, Gaunt T, et al. Neuroblastoma-associated Renal Cell Carcinoma: A Case Report and Review of the Literature. Journal of pediatric hematology/oncology. 2022;44(2):e612-e5.doi.10.1097/MPH.0000000000002251

Krigman HR, Bentley RC, Strickland DK, et al. Anaplastic renal cell carcinoma following neuroblastoma. Medical and pediatric oncology. 1995;25(1):52-9.doi.10.1002/mpo.2950250111

Al-Mashaikhi N, Yang J, Terry J, et al. Renal cell carcinoma with Xp 11.2 translocation as a second tumor in a long-term survivor of advanced neuroblastoma. Pediatric hematology and oncology. 2015;32(3):215-22.doi.10.3109/08880018.2014.979457

Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. The American journal of surgical pathology. 2003;27(5):612-24.doi.10.1097/00000478-200305000-00005

Bacalbasa N, Balescu I, Jinescu G, et al. Fat-forming Solitary Fibrous Tumor of the Kidney - A Case Report and Literature Review. In vivo. 2018;32(3):649-52.doi.10.21873/invivo.11288

De Luca L, Creta M, Barone B, et al. A case of incidentally discovered solitary fibrous tumor of the kidney: A case study. Molecular and clinical oncology. 2020;13(4):39.doi.10.3892/mco.2020.2109

Chick JF, Chauhan NR, Madan R. Solitary fibrous tumors of the thorax: nomenclature, epidemiology, radiologic and pathologic findings, differential diagnoses, and management. AJR American journal of roentgenology. 2013;200(3):W238-48.doi.10.2214/AJR.11.8430

Zhang L, Tang L, Zhang T, et al. Solitary fibrous tumor of the kidney with severe hypoglycemia and hypokalemia: A case report. Asian journal of surgery. 2022.doi.10.1016/j.asjsur.2022.08.056

Kuroda N, Ohe C, Sakaida N, et al. Solitary fibrous tumor of the kidney with focus on clinical and pathobiological aspects. International journal of clinical and experimental pathology. 2014;7(6):2737-42

Zaghbib S, Chakroun M, Essid MA, et al. Solitary fibrous tumor of the kidney: A case report. International journal of surgery case reports. 2019;62:112-4.doi.10.1016/j.ijscr.2019.08.004

Izumi K, Inoue M, Maruyama R, et al. Dedifferentiated solitary fibrous tumor of the kidney: A case report. Urology case reports. 2022;43:102100.doi.10.1016/j.eucr.2022.102100

Argani P, Kao YC, Zhang L, et al. BCOR Overexpression in Renal Malignant Solitary Fibrous Tumors: A Close Mimic of Clear Cell Sarcoma of Kidney. The American journal of surgical pathology. 2019;43(6):773-82.doi.10.1097/PAS.0000000000001243

Kopel J, Sharma P, Warriach I. A solitary fibrous tumor of the kidney. Urology case reports. 2020;28:101072.doi.10.1016/j.eucr.2019.101072

Xie Z, Zhu G, Cheng L, et al. Solitary fibrous tumor of the kidney: Magnetic resonance imaging characteristics in 4 patients. Medicine. 2018;97(34):e11911.doi.10.1097/ MD.0000000000011911

Sato K, Ueda Y, Tachibana H, et al. Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: an autopsy case report with p53 gene mutation analysis. Pathology, research and practice. 2008;204(10):771-7.doi.10.1016/j.prp.2008.04.008

Parekh V, Shen D. Invasive Renal Angiomyolipoma With Cytologic Atypia. International journal of surgical pathology. 2017;25(2):177-80.doi.10.1177/1066896916665700

Ferry JA, Malt RA, Young RH. Renal angiomyolipoma with sarcomatous transformation and pulmonary metastases. The American journal of surgical pathology. 1991;15(11):1083-8.doi.10.1097/00000478-199111000-00008

Matute Martinez CF, Hamdan A, Sierra David JG, et al. Sporadic, classic-type renal angiomyolipoma with renal vein and inferior vena cava extension: an incidental case. BMJ case reports. 2021;14(3).doi.10.1136/bcr-2020-237376

Beardo P, Jose Ledo M, Jose Luis RC. Renal leiomyosarcoma. Rare tumors. 2013;5(3):e42.doi.10.4081/rt.2013.e42

Miller JS, Zhou M, Brimo F, et al. Primary leiomyosarcoma of the kidney: a clinicopathologic study of 27 cases. The American journal of surgical pathology. 2010;34(2):238-42.doi.10.1097/PAS.0b013e3181cad8c9

Novak M, Perhavec A, Maturen KE, et al. Leiomyosarcoma of the renal vein: analysis of outcome and prognostic factors in the world case series of 67 patients. Radiology and oncology. 2017;51(1):56-64.doi.10.1515/raon-2016-0051

Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Annals of surgical oncology. 2015;22(1):256-63.doi.10.1245/s10434-014-3965-2

Soni K, Elhence P, Kesarwani A, et al. Primary Ewing's Sarcoma of Zygoma. Annals of maxillofacial surgery. 2019;9(2):419-22.doi.10.4103/ams.ams_267_18

Mubarak M, Kazi JI, Mohsin R, et al. Histopathology of surgically treated renal tumours in young adults: a developing country perspective. Journal of cancer research and clinical oncology. 2012;138(2):189-94.doi.10.1007/s00432-011-1082-1

Doroudinia A, Ahmadi S, Mehrian P, et al. Primary Ewing sarcoma of the kidney. BMJ case reports. 2019;12(1).doi.10.1136/bcr-2018-227198

Hakky TS, Gonzalvo AA, Lockhart JL, et al. Primary Ewing sarcoma of the kidney: a symptomatic presentation and review of the literature. Therapeutic advances in urology. 2013;5(3):153-9.doi.10.1177/1756287212471095

Zollner S, Dirksen U, Jurgens H, et al. Renal Ewing tumors. Annals of oncology : official journal of the European Society for Medical Oncology. 2013;24(9):2455-61.doi.10.1093/annonc/mdt215

Tarek N, Said R, Andersen CR, et al. Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers. 2020;12(10).doi.10.3390/cancers12102927

Peng X, Duan Z, Yin H, et al. Ovarian epithelioid angiosarcoma complicating pregnancy: a case report and review of the literature. The Journal of international medical research. 2021;49(5):3000605211019641.doi.10.1177/ 03000605211019641

Noujaim J, Thway K, Bajwa Z, et al. Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy. Frontiers in oncology. 2015;5:186.doi.10.3389/fonc.2015.00186

Schott I, Liffers ST, Farzaliyev F, et al. Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology. Sarcoma. 2021;2021:9960085.doi.10.1155/2021/9960085

Marletta S, Cavallo E, Ammendola S, et al. Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review. Journal of gastrointestinal cancer. 2021;52(2):771-5.doi.10.1007/s12029-020-00504-x

Papadimitriou VD, Stamatiou KN, Takos DM, et al. Angiosarcoma of kidney: a case report and review of literature. Urology journal. 2009;6(3):223-5

Bhaludin BN, Thway K, Adejolu M, et al. Imaging features of primary sites and metastatic patterns of angiosarcoma. Insights Imaging. 2021;12(1):189-.doi.10.1186/s13244-021-01129-9

Spiker AM, Mangla A, Ramsey ML. Angiosarcoma. StatPearls. Treasure Island (FL)2022.

Lydiatt WM, Shaha AR, Shah JP. Angiosarcoma of the head and neck. American journal of surgery. 1994;168(5):451-4.doi.10.1016/s0002-9610(05)80097-2

Komoto H, Kitajima K, Kawanaka Y, et al. CT Findings of Primary Renal Angiosarcoma. Case reports in oncology. 2021;14(1):212-6.doi.10.1159/000512015

Lodhi HT, Inayat F, Munir A, et al. Primary renal angiosarcoma: a diagnostic and therapeutic challenge. BMJ case reports. 2018;2018.doi.10.1136/bcr-2018-225484

Azzariti A, Porcelli L, Mangia A, et al. Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope? Experimental cell research. 2014;321(2):240-7.doi.10.1016/j.yexcr.2013.12.018

Iacovelli R, Orlando V, Palazzo A, et al. Clinical and pathological features of primary renal angiosarcoma. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2014;8(3-4):E223-6.doi.10.5489/cuaj.1585

Omiyale AO, Carton J. Clinical and Pathologic Features of Primary Angiosarcoma of the Kidney. Current urology reports. 2018;19(2):4.doi.10.1007/s11934-018-0755-6

Yoshida K, Ito F, Nakazawa H, et al. A case of primary renal angiosarcoma. Rare tumors. 2009;1(2):e28.doi.10.4081/rt.2009.e28

Tripathy TP, Patidar Y, Chandel K, et al. Embryonal Rhabdomyosarcoma of the Biliary Tree as a Differential in a Paediatric Patient Presenting with Biliary Dilatation: Not Always a Choledochal Cyst. Acta medica Lituanica. 2022;29(1):112-7.doi.10.15388/Amed.2021.29.1.2

Patel SR, Hensel CP, He J, et al. Epidemiology and survival outcome of adult kidney, bladder, and prostate rhabdomyosarcoma: A SEER database analysis. Rare tumors. 2020;12:2036361320977401.doi.10.1177/ 2036361320977401

Shapiro E, Strother D. Pediatric genitourinary rhabdomyosarcoma. The Journal of urology. 1992;148(6):1761-8.doi.10.1016/s0022-5347(17)37023-4

Gerard PS, Frank R, Wilck E, et al. Imaging of retroperitoneal rhabdomyosarcoma mimicking hypernephroma. Clinical imaging. 1991;15(4):276-9.doi.10.1016/0899-7071(91)90118-f

Dalfior D, Eccher A, Gobbo S, et al. Primary pleomorphic rhabdomyosarcoma of the kidney in an adult. Annals of diagnostic pathology. 2008;12(4):301-3.doi.10.1016/j.anndiagpath.2007.01.005

Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. The American journal of surgical pathology. 2001;25(9):1150-7.doi.10.1097/00000478-200109000-00005

Connor J, Tsui JF, He W, et al. Primary renal embryonal rhabdomyosarcoma in an adult patient. BMJ case reports. 2020;13(1).doi.10.1136/bcr-2019-231000

Lin WC, Chen JH, Westphalen A, et al. Primary Renal Rhabdomyosarcoma in an Adolescent With Tumor Thrombosis in the Inferior Vena Cava and Right Atrium: A Case Report and Review of the Literature. Medicine. 2016;95(21):e3771.doi.10.1097/ MD.0000000000003771

Perez EA, Kassira N, Cheung MC, et al. Rhabdomyosarcoma in children: a SEER population based study. The Journal of surgical research. 2011;170(2):e243-51.doi.10.1016/j.jss.2011.03.001

Romero FR, Rais-Bahrami S, Permpongkosol S, et al. Primary carcinoid tumors of the kidney. The Journal of urology. 2006;176(6 Pt 1):2359-66.doi.10.1016/j.juro.2006.07.129

Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39(6):707-12.doi.10.1097/MPA.0b013e3181ec124e

Lawrence B, Gustafsson B, Chan A. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40:1-18

Begin LR, Guy L, Jacobson SA, et al. Renal carcinoid and horseshoe kidney: a frequent association of two rare entities--a case report and review of the literature. Journal of surgical oncology. 1998;68(2):113-9.doi.10.1002/(sici)1096-9098(199806)68:2<113::aid-jso8>3.0.co;2-9

Tetu B, Ro JY, Ayala AG, et al. Small cell carcinoma of the kidney. A clinicopathologic, immunohistochemical, and ultrastructural study. Cancer. 1987;60(8):1809-14.doi.10.1002/1097-0142(19871015)60:8<1809::aid-cncr2820600823>3.0.co;2-u

Yoo J, Park S, Jung Lee H, et al. Primary carcinoid tumor arising in a mature teratoma of the kidney: a case report and review of the literature. Archives of pathology & laboratory medicine. 2002;126(8):979-81.doi.10.5858/2002-126-0979-PCTAIA

Squires MH, 3rd, Volkan Adsay N, Schuster DM, et al. Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach. Annals of surgical oncology. 2015;22(7):2295-301.doi.10.1245/s10434-015-4471-x

Panagiotidis E, Alshammari A, Michopoulou S, et al. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2017;58(1):91-6.doi.10.2967/jnumed.116.178095

Lane BR, Chery F, Jour G, et al. Renal neuroendocrine tumours: a clinicopathological study. BJU international. 2007;100(5):1030-5.doi.10.1111/j.1464-410X.2007.07116.x

Teegavarapu PS, Rao P, Matrana M, et al. Neuroendocrine tumors of the kidney: a single institution experience. Clinical genitourinary cancer. 2014;12(6):422-7.doi.10.1016/j.clgc.2014.06.008